Medical Fair Asia held in Singapore, a significant opportunity for us to present our innovative technologies and products.

Breaking Ground in Dermatology: AMO Shines at CDA2023 Exhibition in Shanghai!

Once again, AMO has ventured into the limelight, making an indelible impression at China’s prestigious Personal Care and Homecare Ingredients (PCHi) exhibition.

The groundbreaking ApolloVue®S100 has made a great impression among Chinese dermatology experts, marking a significant milestone in the field.

AMO was honored to participate in two prominent beauty industry events in China: the Mevos International Congress of Aesthetic Surgery and Medicine and the China Beauty Expo (CBE).

Apollo Medical Optics (AMO), in collaboration with their distributor, debuted their latest product, the FF-OCT Cellular Skin Perspective System, at the conference.

AMO launches its TFDA approved OCT, ApolloVue® S100 Image System, at the 8th Taiwan Dermatology Aesthetics Conference.

AMO’s cellular resolution FF-OCT system, ApolloVue® S100, made its first appearance at Taiwan Laser and Photonics Medicine Congress 2021.

AMO announced ApolloVue® S100 Image System has received Taiwan FDA approval.